Skip to main content
SpringerLink
Log in

Photochemotherapy

A Reappraisal of its Use in Dermatology

  • Review Article
  • Published:
Drugs Aims and scope Submit manuscript

Summary

Oral psoralen photochemotherapy was introduced for the treatment of psoriasis in the mid-1970s. Since then it has become an established technique, generally giving good clearance rates of affected areas, and its usefulness has extended to treatment of other conditions. It is popular with patients but possible ocular complications must be avoided and the potential for carcinogenesis should be recognised. Although essentially palliative rather than curative, it has achieved major successes in the treatment of psoriasis and cutaneous T-cell lymphoma, and is also of benefit in the management of vitiligo. This article reviews over a decade of clinical and laboratory findings. Therapeutic responses are summarised and consideration is given to the protection of patients and staff.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Abel EA, Cox AJ, Farber EM. Epidermal dystrophy and actinic kertoses in psoriasis patients following oral psoralen photochemotherapy (PUVA). Journal of the American Academy of Dermatology 7: 333–340, 1982

    Article  CAS  PubMed  Google Scholar 

  • Addo HA, Sharma SC. UVB phototherapy and photochemotherapy (PUVA) in the treatment of polymorphic light eruption and solar urticaria. British Journal of Dermatology 116: 539–547, 1987

    Article  CAS  PubMed  Google Scholar 

  • Baydoun S, Young A. Furocoumarin photosensitization: wavelength dependence of monoaduct and crosslink formation in yeast. In Moreno G et al. (Eds) Photosensitization, pp. 305–310, Springer-Verlag, Berlin, 1988

    Chapter  Google Scholar 

  • Bickers DR. Photochemotherapy of psoriasis: risk:benefit ratio. Journal of the American Academy of Dermatology 4: 90–93. 1981

    Article  CAS  PubMed  Google Scholar 

  • Bickers DR. Position paper — PUVA therapy. Journal of the American Academy of Dermatology 8: 265–270, 1983

    Article  CAS  PubMed  Google Scholar 

  • Bleehen SS. Freckles induced by PUVA treatment. British Journal of Dermatology 99: 20, 1978

    Article  CAS  PubMed  Google Scholar 

  • Brickl R, Schmid J, Koss FW. Clinical pharmacology of oral psoralen drugs. Photodermatology 1: 174–186, 1984

    CAS  PubMed  Google Scholar 

  • Buck HW, Magnus IA, Porter AD. The action spectrum of 8-methoxypsoralen for erythema in human skin. British Journal of Dermatology 72: 249–255, 1960

    Article  CAS  PubMed  Google Scholar 

  • Cloud TM, Hakim R, Griffin AC. Photosensitization of the eye with methoxsalen. Archives of Ophthalmology 64: 346–351, 1960

    Article  CAS  PubMed  Google Scholar 

  • Cox AJ, Abel EA. Epidermal dystrophy: occurrence after psoriasis therapy with psoralen and long-wave ultraviolet light. Archives of Dermatology 115: 567–570, 1979

    Article  CAS  PubMed  Google Scholar 

  • Cox NH, Jones SK, Downey DJ, Tuyp EJ, Japy JL, et al. Cutaneous and ocular side-effects of oral photochemotherapy. British Journal of Dermatology 116: 145–152, 1987

    Article  CAS  PubMed  Google Scholar 

  • Cripps DT, Lowe KJ, Lerner AB. Action spectra of topical psoralens: a re-evaluation. British Journal of Dermatology 107: 77–82, 1982

    Article  CAS  PubMed  Google Scholar 

  • Davey JB, Diffey BL, Miller JA. Eye protection in psoralen photochemotherapy. British Journal of Dermatology 104: 295–300, 1981

    Article  CAS  PubMed  Google Scholar 

  • Edelson R, Berger C, Gassparro F, Jegasothy B, Heald P, et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. New England Journal of Medicine 316: 297–303, 1987

    Article  CAS  PubMed  Google Scholar 

  • Ehrsson H, Nilsson SO, Ehrnebo M, Wallin I, Wennersten G. Effects of food on kinetics of 8-MOP. Clinical Pharmacology and Therapeutics 25: 167–171, 1979

    CAS  PubMed  Google Scholar 

  • Eskelinen A, Halme K, Lassus A, Idanpaan-Heikkila J. Risk of cutaneous carcinoma in psoriatic patients treated with PUVA. Photodermatology 2: 10–14, 1985

    CAS  PubMed  Google Scholar 

  • Farber EM, Abel EA, Cox AJ. Long-term risk of psoralen and UV-A therapy for psoriasis. Archives of Dermatology 119: 426–431, 1983

    Article  CAS  PubMed  Google Scholar 

  • Farr PM, Diffey BL. Treatment of actinic prurigo with PUVA: mechanism of action. British Journal of Dermatology 120: 411–418, 1989

    Article  CAS  PubMed  Google Scholar 

  • Fenton DA, Wilkinson JD. Dose-related visual field defects in patients receiving PUVA therapy. Lancet 1: 1106, 1983

    Article  CAS  PubMed  Google Scholar 

  • Forrest JB, Forrest JH. Malignant melanoma arising during drug therapy for vitiligo. Journal of Surgery and Oncology 12: 337–340, 1980

    Article  Google Scholar 

  • Freeman RG, Troll D. Photosensitization of the eye by 8-methoxypsoralen. Journal of Investigative Dermatology 53: 449–453, 1969

    CAS  PubMed  Google Scholar 

  • Fritsch P, Honigsmann H. Combination phototherapy: a critical reappraisal. Current Problems in Dermatology 15: 238–253, 1986

    CAS  PubMed  Google Scholar 

  • Fulton Jr JE, Leyden J, Papa C. Treatment of vitiligo with topical methoxsalen and blacklite. Archives of Dermatology 100: 224–229, 1969

    Article  PubMed  Google Scholar 

  • Gibbs NK, Honigsmann H, Young AR. PUVA treatment strategies and cancer risk. Lancet 1: 150–151, 1986

    Article  CAS  PubMed  Google Scholar 

  • Gilchrist A, Parrish JA, Tannenbaum L, Hagnes HA, Fitzpatrick TB. Oral methoxsalen photochemotherapy of mycosis fungoides. Cancer 38: 683–689, 1976

    Article  Google Scholar 

  • Gould PW, Wilson L. Psoriasis treated with clobetasol proprionate and photochemotherapy. British Journal of Dermatology 98: 133–136, 1978

    Article  CAS  PubMed  Google Scholar 

  • Gschnait F, Wolff K, Honigsmann H. Long-term photochemotherapy. British Journal of Dermatology 103: 11–22, 1980

    Article  CAS  PubMed  Google Scholar 

  • Guiotto A, Rodighiero P, Manxinin P, Pastorini G, Bordin F, et al. 6-methylangelicin: a new series of potential photochemotherapeutic agents for the treatment of psoriasis. Journal of Medical Chemistry 27: 959–967, 1984

    Article  CAS  Google Scholar 

  • Hammershoy O, Jessen F. A retrospective study of cataract formation in 96 patients treated with PUVA. Acta Dermato-Venereologica 62: 444–446, 1982

    CAS  PubMed  Google Scholar 

  • Hashimoto K, Kumakiri M. Colloid-amyloid bodies in PUVA treated human psoriatic patients. Journal of Investigative Dermatology 72: 70–80, 1979

    Article  CAS  PubMed  Google Scholar 

  • Henseler T, Christophers E, Honigsmann H, Wolff K. Skin tumours in the European PUVA study. Journal of the American Academy of Dermatology 16: 108–116, 1987

    Article  CAS  PubMed  Google Scholar 

  • Henseler T, Wolff K, Honigsmann H, Christophers E. Oral 8-methoxypsoralen photochemotherapy of psoriasis: the European study; a co-operative study among 18 European centres. Lancet 1: 853–857, 1981

    Article  CAS  PubMed  Google Scholar 

  • Herfst MF, Wolff FA. Influence of food on the kinetics of 8-MOP in serum and suction blister fluid in psoriatic patients. European Journal of Clinical Pharmacology 23: 75–80, 1982

    Article  CAS  PubMed  Google Scholar 

  • Honigsmann H, Jaschke E, Gschnait F, Brenner W, Fritsch P, et al. 5-Methoxypsoralen (Bergapten) in photochemotherapy of psoriasis. British Journal of Dermatology 101: 369–378, 1979

    Article  CAS  PubMed  Google Scholar 

  • Kaidbey KH. An action spectrum for 8-methoxypsoralen-sensitized inhibition of DNA synthesis in vivo. Journal of Investigative Dermatology 85: 98–101, 1985

    Article  CAS  PubMed  Google Scholar 

  • Kemmett D, Reshad H, Baker H. Nodular malignant melanoma and multiple squamous cell carcinomas in a patient treated by photochemotherapy for psoriasis. British Medical Journal 289: 1498, 1984

    Article  CAS  PubMed  Google Scholar 

  • Kenicer KJA, Lakshmipathi T, Addo HA, Johnson BE, FrainBell W. An assessment of the effect of photochemotherapy (PUVA) and UV-B phototherapy in the treatment of psoriasis. British Journal of Dermatology 105: 629–639, 1981

    Article  CAS  PubMed  Google Scholar 

  • Lafond G, Roy PE, Grenier R. Lens opacities appearing during therapy with methoxsalen and long-wavelength ultraviolet radiation. Canadian Journal of Ophthalmology 19: 173–175, 1984

    CAS  PubMed  Google Scholar 

  • Lassus A, Reunala T, Idanpaan-Heikkila J, Juvakoski T, Salo O. PUVA treatment and skin cancer: a follow-up study. Acta Dermato-Venereologica 61: 141–145, 1981

    CAS  PubMed  Google Scholar 

  • Lerman S, Megaw J, Garner K. Psoralen-long wave ultraviolet therapy and human cataractogenesis. Investigative Ophthalmology 23: 801–804, 1982

    CAS  Google Scholar 

  • Lerman S, Megaw J, Willis I. Potential ocular complications from PUVA therapy and their prevention. Journal of Investigative Dermatology 74: 197–199, 1980

    Article  CAS  PubMed  Google Scholar 

  • Levins PC, Gange RW, Momtaz TK, Parrish JA, Fitzpatrick TB. A new liquid formulation of 8-methoxypsoralen: bioactivity and effect of diet. Journal of Investigative Dermatology 82: 185–187, 1984

    Article  CAS  PubMed  Google Scholar 

  • Lobel E, Paver K, King R, Le Guay J, Pozzer K, et al. The relationship of skin cancer to PUVA therapy in Australia. Australasian Journal of Dermatology 22: 100–103, 1981

    Article  CAS  PubMed  Google Scholar 

  • Lowe NJ, Urbach F, Bailion P, Weingarten DPP. Comparative efficacy of two dosage forms of oral methoxsalen in psoralens plus ultraviolet A therapy of psoriasis. Journal of the American Academy of Dermatology 16: 994–998, 1987

    Article  CAS  PubMed  Google Scholar 

  • Marx JL, Auerbach R, Possick P, Myrow R, Gladstein AH, et al. Malignant melanoma in situ in two patients treated with psoralens and ultraviolet A. Journal of the American Academy of Dermatology 9: 904–911, 1983

    Article  CAS  PubMed  Google Scholar 

  • Melski JW, Tannenbaum L, Parrish JA, Fitzpatrick TB, Bleich HL. Oral methoxsalen photochemotherapy for the treatment of psoriasis: a co-operative clinical trial. Journal of Investigative Dermatology 68: 328–335, 1977

    Article  CAS  PubMed  Google Scholar 

  • Morison WL, Montaz K, Parrish JA, Fitzpatrick TB. Combined methotrexate-PUVA in the treatment of psoriasis. Journal of the American Academy of Dermatology 6: 46–51, 1982

    Article  CAS  PubMed  Google Scholar 

  • Morison WL, Parrish JA, Fitzpatrick TB. Controlled study of PUVA and adjunctive topical therapy in the management of psoriasis. British Journal of Dermatology 98: 125–132, 1978

    Article  CAS  PubMed  Google Scholar 

  • Mortazawi SAM. Meladinine mit UVA bei vitiligo, psoriasis, parapsoriasis under akne vulgaris. Dermatologische Monatsschrift 158: 908–911, 1972

    Google Scholar 

  • Moseley H. Non-ionising radiation, Adam Hilger, Bristol, 1988

  • Moseley H, Cox NH, MacKie RM. The suitability of sunglasses used by patients following ingestion of psoralen. British Journal of Dermatology 118: 247–253, 1988

    Article  CAS  PubMed  Google Scholar 

  • Moseley H, Davison M, MacDonald I. A system for solar radiation data storage and analysis. Photodermatology 3: 249–255, 1986

    CAS  PubMed  Google Scholar 

  • Moseley H, Davison M, MacKie RM. Measurements of daylight UVA in Glasgow. Physics in Medicine and Biology 28: 589–597, 1983

    Article  CAS  PubMed  Google Scholar 

  • Moseley H, Diffey BL, Marks JM, MacKie RM. Personal solar UVA doses received by patients undergoing oral psoralen photochemotherapy for psoriasis. British Journal of Dermatology 105: 573–577, 1981

    Article  CAS  PubMed  Google Scholar 

  • Mutzhas MF, Holzle E, Hofmann C, Plewig G. A new apparatus with high radiation energy between 320–460nm: physical description and dermatological applications. Journal of Investigative Dermatology 76: 42–47, 1981

    Article  CAS  PubMed  Google Scholar 

  • Nakagawa H, Rhodes AR, Momtaz-TK, Fitzpatrick TB. Morphologic alterations of epidermal melanocytes and melanosomes in PUVA lentigines. Journal of Investigative Dermatology 82: 101–107, 1984

    Article  CAS  PubMed  Google Scholar 

  • Niemi K-M, Niemi A, Kanerva L. Morphologic changes in epidermis of PUVA treated patients with psoriasis with or without a history of arsenic therapy. Archives of Dermatology 119: 904–909, 1983

    Article  CAS  PubMed  Google Scholar 

  • Ortell B, Tanew A, Honigsmann H. Vitiligo treatment. In Honigsmann H (Ed.) Current problems in dermatology, vol.16, pp. 265–271, Karger, Basel, 1986

    Google Scholar 

  • Parrish JA, Fitzpatrick TB, Tanenbaum L, Pathak MA. Photochemotherapy of psoriasis with oral methoxsalen and long-wave ultraviolet light. New England Journal of Medicine 291: 1207–1211, 1974

    Article  CAS  PubMed  Google Scholar 

  • Pathak MA. Mechanisms of psoralen photosensitization reactions. National Cancer Institute Monograph 66: 41–46, 1984

    CAS  PubMed  Google Scholar 

  • Pathak MA, Daniels F, Hopkins CE, Fitzpatrick TB. Ultraviolet carcinogenesis in albino and pigmented mice receiving furocoumarins: psoralen and 8-methoxypsoralen. Nature 183: 728–730, 1959

    Article  CAS  PubMed  Google Scholar 

  • Pathak MA, Joshi PC. Production of active oxygen species (1O2 and O2) 1O2 by psoralens and ultraviolet radiation (320-400n). Biochimica et Biophysica Acta 798: 115–126, 1984

    Article  CAS  PubMed  Google Scholar 

  • Pathak MA, Mosher BD, Fitzpatrick TB, Parrish JA. Relative effectiveness of three psoralens and sunlight in repigmentation of 365 vitiligo patients. Journal of Investigative Dermatology 74: 252, 1980

    Google Scholar 

  • Pierard GE, Ackerman AB. Histopathology of remodelling induced by PUVA in the superficial dermis. British Journal of Dermatology 100: 251–256, 1979

    Article  CAS  PubMed  Google Scholar 

  • Pierard GE, Franchimont C, Van Cauwenberge D. PUVA and specific changes in the superficial dermis. In Farber EM & Cox AJ (Eds) Proceedings of the Third International Symposium on Psoriasis, pp. 459–460, Grune and Stratton Inc, New York, 1982

    Google Scholar 

  • Plewig G, Holzle E, Lehmann P. Phototherapy for the photodermatoses. In Honigsmann H (Ed.) Current problems in dermatology, vol. 15, pp. 254–264, Karger, Basel, 1986

    Google Scholar 

  • Powell FC, Spiegel GT. Treatment of parapsoriasis and mycosis fungoides: the role of psoralen and long wave ultraviolet light A (PUVA). May Clinic Proceedings 59: 538–546, 1984

    Article  CAS  Google Scholar 

  • Ree K. Reduction of Langerhans cells in human epidermis during PUVA therapy. Journal of Investigative Dermatology 78: 488–492, 1982

    Article  CAS  PubMed  Google Scholar 

  • Reshad H, Challoner F, Pollock DJ, Baker H. Cutaneous carcinoma in psoriatic patients treated with PUVA. British Journal of Dermatology 110: 299–305, 1984

    Article  CAS  PubMed  Google Scholar 

  • Rhodes AR, Stern RS, Melski JW. The PUVA lentigo: an analysis of predisposing factors. Journal of Investigative Dermatology 81: 459–463, 1983

    Article  CAS  PubMed  Google Scholar 

  • Roenigk HH. Photochemotherapy for psoriasis. Archives of Dermatology 115: 576–579, 1979

    Article  Google Scholar 

  • Rogers S, Marks J, Shuster S, Hillyard CJ. Effect of PUVA on serum 25-OH vitamin D in psoriatics. British Medical Journal 2: 833–834, 1979

    Article  CAS  PubMed  Google Scholar 

  • Ros A-M, Wennersten G, Lagerholm B. Long-term photochemotherapy for psoriasis. Acta Dermato-Venereologica 63: 215–221, 1983

    CAS  PubMed  Google Scholar 

  • Souteyrand P, Thivolet J, Fulton R. Treatment of parapsoriasis on plaques and mycosis fungoides with an oral aromatic retinoid (RO 10-9359). In Orfanos CE (Ed.) Retinoids: advances in basic research and therapy, pp. 313–316, Springer, Berlin, 1981

    Google Scholar 

  • Stern RS, Laird N, Melski J, Parrish JA, Fitzpatrick TB, et al. Cutaneous squamous cell carcinoma in patients treated with PUVA. New England Journal of Medicine 310: 1156–1161, 1984

    Article  CAS  PubMed  Google Scholar 

  • Stern RS, Parrish JA, Fitzpatrick TB. Ocular findings in patients treated with PUVA. Journal of Investigative Dermatology 85: 269–273, 1985

    Article  CAS  PubMed  Google Scholar 

  • Strauss GH, Bridges BA, Greaves M, Hall-Smith P, Price M, et al. Inhibition of delayed hypersensitivity reaction in skin (DNCB test) by 8-methoxypsoralen photochemotherapy. Lancet 2: 556–559, 1980

    Article  CAS  PubMed  Google Scholar 

  • Tanew A, Ortel B, Wolff K, Honigsmann H. PUVA for cutaneous T-cell lymphoma: 10 years after. In Honigsmann H (Ed.) Current problems in dermatology, Vol. 15, pp. 232–237, Karger, Basel, 1986

    Google Scholar 

  • Turjammaa K, Salo H, Rennala T. Comparison of trioxsalen bath and oral methoxsalen PUVA in psoriasis. Acta Dermato-Venereologica (Stockholm) 65: 86–88, 1985

    Google Scholar 

  • Volden G. PUVA. In Mier PD & van de Kerkhof PCM (Eds) Text book of psoriasis, pp. 211–232, Churchill-Livingstone, 1986

  • Weber G. Photochemotherapy. Year Book Medical Publishers, Chicago, London, 1980

    Google Scholar 

  • Wolff K. PUVA Klinik and Praxis. In Braun-Falco O & Wolff HH (Eds) Fortschritte der praktischen Dermatologie und Venereologie, BD9 pp. 129–138, Springer Verlag, Berlin-Heidelberg, 1979

    Google Scholar 

  • Wolff K, Honigsmann H. Safety and therapeutic effectiveness of selected psoralens in psoriasis. National Cancer Institute Monograph 66: 159–164, 1984

    CAS  PubMed  Google Scholar 

  • Woo TY, Wong RC, Wong JM, Anderson TF, Lerman S. Lenticular psoralen photoproducts and cataracts of a PUVA-treated psoriatic patient. Archives of Dermatology 121: 1307–1308, 1985

    Article  CAS  PubMed  Google Scholar 

  • Young AR, Magnus IA, Davies AC, Smith NP. A comparison of the phototumorigenic potential of 8-MOP and 5-MOP in hairless albino mice exposed to solar simulated radiation. British Journal of Dermatology 108: 507–518, 1983

    Article  CAS  PubMed  Google Scholar 

  • Zelickson AS, Mottaz JH, Muller SA. Melanocyte changes following PUVA therapy. Journal of the American Academy of Dermatology 1: 422–430, 1979

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Physics and Bio-Engineering, West of Scotland Health Boards, 11 West Graham Street, Glasgow, G4 9LF, Scotland

    Harry Moseley & James Ferguson

  2. Photobiology Unit, Ninewells Hospital, Dundee, Scotland

    Harry Moseley & James Ferguson

Authors
  1. Harry Moseley
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. James Ferguson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moseley, H., Ferguson, J. Photochemotherapy. Drugs 38, 822–837 (1989). https://doi.org/10.2165/00003495-198938050-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-198938050-00007

Keywords

Search

Navigation